Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer

NCT01276041 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: pertuzumab in combination with trastuzumab and paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]